Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
RFK Jr. adopts new chikungunya vaccine guidance; other recommendations remain under review
3 weeks ago
R&D
FDA+
'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure
3 weeks ago
Manufacturing
Regeneron scores $400M+ jury win in Amgen cholesterol drug spat
3 weeks ago
Law
Eisai says Leqembi is headed for 'demand expansion phase' in US
3 weeks ago
New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says
3 weeks ago
FDA+
Bristol Myers CEO says America’s biopharma pole position is not guaranteed
3 weeks ago
People
Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege
3 weeks ago
In Focus
Health Tech
Updated: Merck KGaA continues US tariff surcharge but at a 'decreased' rate
3 weeks ago
China
Manufacturing
Biohaven stock sinks on three-month delay for neuro drug's FDA approval decision
3 weeks ago
FDA+
Hengrui, one of China's leading biotechs, anticipates $1.2B in proposed Hong Kong listing
3 weeks ago
Financing
China
RFK Jr. defends HHS staff cuts, reorganization plans in House, Senate hearings
3 weeks ago
FDA+
RFK Jr. says his opinions of vaccines are ‘irrelevant.’ Former FDA chief Califf disagrees
3 weeks ago
FDA+
Sanofi touts $20B investment in US over five years
3 weeks ago
Manufacturing
FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer
3 weeks ago
FDA+
AbbVie doubles down on siRNA with $335M upfront bet on ADARx
3 weeks ago
Startups
Deals
GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope
3 weeks ago
Deals
Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B
3 weeks ago
Deals
HHS focuses on 'transparency' in third-round IRA negotiation guidance
3 weeks ago
Law
Some generics, biosimilar drugmakers say they can withstand tariff impact
3 weeks ago
Manufacturing
Watch Post-Hoc Live: Trump's 'most favored nation' plan to cut drug prices
3 weeks ago
Bayer starts 2025 by cutting 2,000 jobs as it homes in on year-end rehaul target
3 weeks ago
People
Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise
3 weeks ago
Lack of detail in Trump's drug price plan raises more questions than answers
3 weeks ago
Law
PBM overhaul and drug price negotiations make the cut in Republicans' tax bill
3 weeks ago
Law
First page
Previous page
1
2
3
4
5
6
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit